REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 23rd, 2007 • IntelGenx Technologies Corp. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of May 22, 2007, between IntelGenx Technologies Corp., a Delaware corporation (the “Company”) and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
COMMON STOCK PURCHASE WARRANT INTELGENX TECHNOLOGIES CORP.Security Agreement • May 23rd, 2007 • IntelGenx Technologies Corp. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the 5 year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from IntelGenx Technologies Corp., a Delaware corporation (the “Company”), up to ____ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
8% SENIOR SECURED CONVERTIBLE DEBENTURE DUE SEPTEMBER 22, 2009Convertible Security Agreement • May 23rd, 2007 • IntelGenx Technologies Corp. • Pharmaceutical preparations • New York
THIS DEBENTURE is one of a series of duly authorized and validly issued 8% Senior Secured Convertible Debentures of IntelGenx Technologies Corp., a Delaware corporation, (the “Company”), having its principal place of business at 6425 Abrams, Ville Saint Laurent, Quebec, Canada H4S 1X9, designated as its 8% Senior Secured Convertible Debenture due September 22, 2009 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
SECURITY AGREEMENTSecurity Agreement • May 23rd, 2007 • IntelGenx Technologies Corp. • Pharmaceutical preparations • New York
This SECURITY AGREEMENT, dated as of May 22, 2007 (this “Agreement”), is among IntelGenx Technologies Corp., a Delaware corporation (the “Company”), all of the Subsidiaries of the Company (such subsidiaries, the “Guarantors” and together with the Company, the “Debtors”) and the holders of the Company’s 8% Senior Secured Convertible Debentures due September 22, 2009 and issued on May 22, 2007 in the original aggregate principal amount of up to $4,500,000 (collectively, the “Debentures”) signatory hereto, their endorsees, transferees and assigns (collectively, the “Secured Parties”).
SUBSIDIARY GUARANTEESubsidiary Guarantee • May 23rd, 2007 • IntelGenx Technologies Corp. • Pharmaceutical preparations • New York
SUBSIDIARY GUARANTEE, dated as of May 22, 2007 (this “Guarantee”), made by each of the signatories hereto (collectively, together with any other entity that may become a party hereto as provided herein, the “Guarantors”), in favor of the purchasers signatory (the “Purchasers”) to that certain Securities Purchase Agreement, dated as of the date hereof, between IntelGenx Technologies Corp., a Delaware corporation (the “Company”) and the Purchasers.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 23rd, 2007 • IntelGenx Technologies Corp. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 22, 2007 between IntelGenx Technologies Corp., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
DEED OF MOVABLE HYPOTHECDeed of Movable Hypothec • May 23rd, 2007 • IntelGenx Technologies Corp. • Pharmaceutical preparations • Quebec
WHEREAS to secure the Obligations the Guarantor has undertaken to grant a hypothec on the Collateral in favour of the Purchasers;
